Development and use of human pancreatic cell lines

Chemistry: molecular biology and microbiology – Process of mutation – cell fusion – or genetic modification – Introduction of a polynucleotide molecule into or...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

4353201, 435325, 435366, C12N 510, C12N 1563

Patent

active

061107433

ABSTRACT:
This invention relates to cell lines, particularly mammalian cell lines, established by transforming the cells with vectors, preferably retroviral vectors, containing two or more oncogenes under the control of one or more inducible promoters and/or genetic elements. Also within the scope of the invention are human cell lines with extended in vitro lifespan, transformed by vectors containing one or more oncogenes under the control of one or more, preferably exogenous, inducible promoters and/or genetic elements. The vectors may additionally contain gene(s) encoding for desired gene product(s). Also disclosed are insulin producing human pancreatic cell lines useful for transplantation into human diabetic patients.

REFERENCES:
patent: 5256553 (1993-10-01), Overell
patent: 5629159 (1997-05-01), Anderson
patent: 5723333 (1998-03-01), Levine et al.
Yarranton (1992) Inducible vectors for expression in mammalian cells. Curr. Opin. Biotechnol. 3:506-511, Oct. 1992.
Baekkeskov, S. et al., "Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins" Nature 298:167-169 (1982).
Bartek, J. et al., "Efficient immortalization of luminal epithelial cells from human mammary gland by introduction of simian virus 40 large tumor antigen with a recombinant retrovirus" Proc. Natl. Acad. Sci. USA 88:3520-3524 (1991).
Beattie, G.M., et al., "Acid .beta.-Galactosidase: A Developmentally Regulated Marker of Endocrine Cell Precursors in the Human Fetal Pancreas" J. Clin. Endocr. Metab. 78:1232 (1994).
Burns, J.C. et al., "Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells" Proc. Natl. Acad. Sci. USA 90:8033-8037 (1993).
Chou, J.Y., "Differentiated Mammalian Cell Lines Immortalized by Temperature-Sensitive Tumor Viruses" Mol. Endocrinol. 3(10):1511-1514 (1989).
Clark, S.A. et al., "Modulation of Glucose-Induced Insulin Secretion from a Rat Clonal .beta.-Cell Line" Endocrinol. 127(6):2779-2788 (1990).
Dale, E.C. and Ow, D.W., "Gene transfer with subsequent removal of the selection gene from the host genome" Proc. Natl. Acad. Sci. USA 88:10558-10562 (1991).
Efrat, S. et al., ".beta.-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene" Proc. Natl. Acad. Sci. USA 85:9037-9041 (1988).
Efrat, S. et al., "Conditional transformation of a pancreatic .beta.-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene" Proc. Natl. Acad. Sci. USA 92:3576-3580 (1995).
Efrat, S. et al., "Development of Correctly Regulated Pancreatic B-cell Lines" J. Cellular Biochem. Suppl. 21B:4 (1995).
Eilers, M. et al., "Chimaeras of Myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells" Nature 340:66-68 (1989).
Epstein-Baak, R. et al., "Inducible Transformation of Cells from Transgenic Mice Expressing SV40 under lac Operon Control" Cell Growth Diff. 3:127-134 (1992).
Figge, J. et al., "Stringent Regulation of Stably Integrated Chloramphenicol Acetyl Transferase Genes by E. coli lac Repressor in Monkey Cells" Cell 52:713-722 (1988).
Gilligan, A. et al., "Functional Pancreatic .beta.-Cell Line From SV40 T-Antigen Transgenic Mouse" Diabetes 38:1056-1062 (1989).
Gueli, N. et al., "In vitro growth of a cell line originated from a human insulinoma" Exp. Clin. Cancer Res. 6(4):281-285 (1987).
Hughes, S.D. et al., "Engineering of glucose-stimulated insulin secretion and biosynthesis in non-islet cells" Proc. Natl. Acad. Sci. USA 89:688-692 (1992).
Jang, S.K. et al., "A Segment of the 5' Nontranslated Region of Encephalomyocarditis Virus RNA Directs Internal Entry of Ribosomes during In Vitro Translation" J. Virol. 62(8):2636-2643 (1988).
Jehn, B. et al., "Overexpression of Mos, Ras, Src, and Fos Inhibits Mouse Mammary Epithelial Cell Differentiation" Mol. Cell Biol. 12(9):3890-3902 (1992).
Knaack, D. et al., "Clonal Insulinoma Cell Line That Stably Maintains Correct Glucose Responsiveness" Diabetes 43:1413-1417 (1994).
Larsen, J. et al., "The v-ski oncogene cooperates with the v-sea oncogene in erythoid transformation by blocking erythoid differentiation" Oncogene 7:1903-1911 (1992).
Levine, F. et al., "Development of a Cell Line From the Human Fetal Pancreas" Transplantation Proc. 27(6):3410 (1995).
Levine, F. et al., "Efficient gene expression in mammalian cells from a dicistronic transcriptional unit in an improved retroviral vector" Gene 108:167-174 (1991).
Liloglou et al., "Inducible H-ras gene expression controlled by an allosterically regulated transactivator" Oncology Reports 1:889-893 (1994).
Liu et al., "Control of Ha-ras-medicated mammalian cell transformation by Escherichia coli regulatory elements" Cancer Res. 52:983-989 (1992).
Maniatis et al., in: Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, 2nd Edition (1989).
Miyazaki, J.-I. et al., "Establishment of a Pancreatic .beta. Cell Line That Retains Glucose-Inducible Insulin Secretion: Special Reference to Expression of Glucose Transporter Isoforms" Endocrinol. 127(1):126 (1990).
Newgard, C.B., "Cellular Engineering and Gene Therapy Strategies for Insulin Replacement in Diabetes" Diabetes 43:341-350 (1994).
Paabo, S. et al., "A Short Sequence in the COOH-Terminus Makes an Adenovirus Membrane Glycoprotein a Resident of the Endoplasmic Reticulum" Cell 50:311-317 (1987).
Parks, G.D. et al., "Encephalomyocarditis Virus 3C Protease: Efficient Cell-Free Expression from Clones Which Link Viral 5' Noncoding Sequences to the P3 Region" J. Virol. 60(2):376-384 (1986).
Quaife, C.J. et al., "Pancreatic Neoplasia Induced by ras Expression in Acinar Cells of Transgenic Mice" Cell 48:1023-1034 (1987).
Radvanyl, F. et al., "Pancreatic .beta. Cells Cultured from Individualized Preneoplastic Foci in a Multistage Tumorigenesis Pathway: A Potentially General Technique for Isolating Physiologically Representative Cell Lines" Mol. Cell. Biol. 13(7):4223-4232 (1993).
Rosen, C.A. et al., "Construction of Recombinant Murine Retroviruses That Express the Human T-Cell Leukemia Virus Type II and Human T-Cell Lymphotropic Virus Type III trans Activator Genes" J. Virol. 57(1):379-384 (1986).
Sandgren, E.P. et al., "Pancreatic tumor pathogenesis reflects the causative genetic lesion" Proc. Natl. Acad. Sci. USA 88:93-97 (1991).
Shay, J.W. et al., "Quantification of the Frequency of Immortalization of Normal Human Diploid Fibroblasts by SV40 Large T-Antigen" Exp. Cell Res. 184:109-118 (1989).
Soldevila, G. et al., "Transfection with SV40 Gene of Human Pancreatic Endocrine Cells" J. Autoimmunity 4:381-396 (1991).
Wang, S. et al., "Analysis of a Human Fetal Pancreatic Islet Cell Line" Transplantation Proc. 29:2219 (1997).
Wang, S. et al., "Analysis of a Human Fetal Pancreatic Islet Cell Line" Proc. Am. Assoc. Cancer Res. Annual Meeting 36:182 Abstract No. 1086 (1995).
Wang, S. et al., "Development of a VSV-G protein pseudotyped retroviral vector system expressing dominant oncogenes from a lacO-modified inducible LTR promoter" Gene 182:145-150 (1996).
Wang, S. et al., "Isolation and Characterization of a Cell Line from the Epithelial Cells of the Human Fetal Pancreas" Cell Transplantation 6(1):59-67 (1997).
Westerman, K.A. et al., "Reversible immortalization of mammalian cells mediated by retroviral transfer and site-specific recombination" Proc. Natl. Acad. Sci. USA 93:8971-8976 (1996).
Wold, W.S.M. and Gooding, L.R., "Adenovirus Region E3 Proteins that Prevent Cytolysis by Cytotoxic T Cells and Tumor Necrosis Factor" Mol. Biol. Med. 6:433-452 (1989).
Wolff, J.A., ed., in: Gene Therapeutics, Methods and Applications of Direct Gene Transfer, Birkhauser, Boston, USA (1994).
Yarranton, G.T., "Inducible vectors for expression in mammalian cells" Curr. Opinion Biotechnol. 3:506-511 (1992).
Yee, J.-K. et al., "A general method for the generation of high-titer, pantropic retroviral vectors: Highly efficient infection of primary hepatocytes" Proc. Natl. Acad. Sci. USA 91:9564-9568 (1994).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Development and use of human pancreatic cell lines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Development and use of human pancreatic cell lines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Development and use of human pancreatic cell lines will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1248887

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.